Probes for laser ablation, illumination and viscoelastic injection

A combined microsurgical instrument with laser ablation, illumination, and viscoelastic injection capabilities addresses the complexity and variability of conventional glaucoma surgeries, enhancing surgical efficiency and safety by integrating tissue disruption and fluid injection into a single device.

JP2024541571APending Publication Date: 2024-11-08ALCON INC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
JP2024531632
Authority / Receiving Office
JP · JP
Patent Type
Applications
Current Assignee / Owner
Priority Date
2021-12-01
Filing Date
2022-11-15
Publication Date
2024-11-08

AI Technical Summary

Technical Problem

Conventional glaucoma surgeries involve the use of multiple microsurgical instruments, including mechanical probes for tissue disruption and viscoelastic injection, which adds complexity and variability in outcomes due to surgeon-dependent techniques, and can cause tissue damage.

Method used

A combined microsurgical instrument with integrated laser ablation, illumination, and viscoelastic injection capabilities, featuring a probe with optical fibers for both laser light and illumination, allowing simultaneous tissue disruption and improved visualization, and a port for fluid injection.

Benefits of technology

The combined instrument enables more efficient, less invasive, and safer glaucoma surgeries by reducing the need for multiple instruments, improving surgical precision, and minimizing tissue damage.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 2024541571000001_ABST
    Figure 2024541571000001_ABST
Patent Text Reader

Abstract

A microsurgical instrument having combined illumination, laser cauterization and viscoelastic injection capabilities. The surgical instrument includes a probe having a main lumen and a port at its distal end. The probe may further include one or more optical fibers configured to project laser light and illumination light within the main lumen. The laser light may be emitted from the distal end of the probe to disrupt ocular tissue, while the illumination light may be simultaneously emitted axially or laterally to provide enhanced visibility of the intraocular space during tissue disruption. A viscoelastic fluid may be injected from the port to maintain the integrity of the intraocular space during tissue disruption.
Need to check novelty before this filing date? Find Prior Art

Description

[Technical field]

[0001] FIELD OF THE DISCLOSURE Embodiments of the present disclosure relate generally to small gauge instruments for surgical procedures, and more specifically, to small gauge instruments for glaucoma surgery. [Background technology]

[0002] Glaucoma is a type of eye disorder that damages the optic nerve (the bundle of nerve fibers that carry messages from the eye to the brain) and can lead to severe vision loss or complete blindness. In fact, glaucoma is the leading cause of irreversible blindness worldwide, affecting nearly 80 million people worldwide.

[0003] Glaucoma is often characterized by an increase in eye pressure, called intraocular pressure, which is due to resistance to the drainage of aqueous humor from the eye. Aqueous humor is a clear fluid produced by the eye to provide nourishment to its many structures and to keep the eye pressurized. Aqueous humor typically flows from the ciliary body into the anterior chamber, then through a spongy tissue called the trabecular meshwork, near the front of the eye, to collect in a drainage structure called Schlemm's canal. From there, the aqueous humor flows into collector channels, then into veins, and finally back into the body's circulation. In many forms of glaucoma, aqueous humor does not flow freely through the trabecular meshwork, which causes intraocular pressure to increase, leading to damage to the optic nerve and loss of vision.

[0004] Currently, glaucoma and pre-glaucoma are treated by lowering intraocular pressure with one or more therapies, including medications and various glaucoma surgeries, such as minimally invasive glaucoma surgery (MIGS). Glaucoma surgical procedures generally involve the mechanical disruption of the trabecular meshwork and / or Schlemm's canal to create an aqueous humor outflow pathway, called a "fistula," i.e., a uveoscleral outflow pathway. Examples of such procedures include trabeculectomy, trabeculotomy, and goniotomy. During such procedures, as the fistula is created, a viscoelastic substance can be injected into the trabecular meshwork and / or Schlemm's canal to expand and / or hold the fistula in place and to maintain the integrity of the anterior chamber.

[0005] The disruption of the trabecular meshwork and / or Schlemm's canal and the injection of the viscoelastic material may each be performed by the surgeon using microsurgical instruments inserted through one or more incisions made in the eye. In some circumstances, when multiple instruments are used simultaneously, separate incisions may be provided for each microsurgical instrument. Microsurgical instruments typically used during glaucoma surgery include a mechanical trabeculotomy / goniotomy probe with a cutting blade for dissecting the tissue and a viscoelastic material injection device such as a syringe. During some procedures, illumination is also used, since proper illumination of the trabecular meshwork and / or Schlemm's canal is advantageous for its disruption by the trabeculotomy / goniotomy probe. Therefore, in any glaucoma surgery procedure, more than one microsurgical instrument may be used, unnecessarily increasing the complexity of the procedure.

[0006] Furthermore, the use of conventional trabeculotomy / goniotomy probes can result in variable results from one glaucoma surgery to the next, as the size of the fistula and therefore the effectiveness of the procedure can depend on the surgeon in using the mechanical cutter. Such probes can also present safety concerns, as the mechanical cutter can cause undesirable damage to tissue surrounding the surgical site where it is destroyed. Summary of the Invention [Problem to be solved by the invention]

[0007] Thus, there is a need in the art for improved methods and devices for glaucoma surgery. [Means for solving the problem]

[0008] The present disclosure relates generally to microsurgical instruments for ophthalmic surgical procedures and, more particularly, to microsurgical instruments having combined laser ablation, illumination and viscoelastic injection capabilities.

[0009] In certain embodiments, a surgical instrument for ophthalmic surgery is provided, the surgical instrument including a handle, a probe coupled to the handle, the probe including a tube, a first port formed proximal to a distal end of the tube for injecting a fluid into an intraocular space, an optically clear or transparent window disposed within the distal end of the tube, and one or more optical fibers extending at least partially through the tube, the optical fibers transmitting laser light for illuminating an area proximate the window for ablating ocular tissue, the one or more optical fibers further transmitting illumination light for illumination within a patient's eye.

[0010] So that the above-mentioned features of the present disclosure can be understood in detail, a more particular description of the present disclosure briefly summarized above can be had by reference to embodiments, some of which are illustrated in the accompanying drawings, which should be noted, however, that the accompanying drawings illustrate only exemplary embodiments and are therefore not to be considered as limiting the scope of the invention, other equally effective embodiments being possible. [Brief description of the drawings]

[0011] [Figure 1A] 1 shows a cross-sectional view of the eye and its internal anatomical structures. [Figure 1B] 1B shows an enlarged cross-sectional view of a portion of the eye of FIG. 1A. [Figure 2A] 1 illustrates a portion of a prior art surgical instrument positioned within a patient's eye during glaucoma surgery, in accordance with certain embodiments of the present disclosure. [Figure 2B] 1 illustrates a portion of a prior art surgical instrument positioned within a patient's eye during glaucoma surgery, in accordance with certain embodiments of the present disclosure. [Diagram 3] 1 illustrates a perspective view of an exemplary surgical instrument in accordance with a specific embodiment of the present disclosure; [Figure 4A] 4 illustrates a top view of a portion of the surgical instrument of FIG. 3 in accordance with a specific embodiment of the present disclosure. [Figure 4B] 4 shows a stylized longitudinal cross-sectional view of a portion of the surgical instrument of FIG. 3 according to some embodiments of the present disclosure. [Figure 4C]4 shows a stylized longitudinal cross-sectional view of a portion of the surgical instrument of FIG. 3 according to some embodiments of the present disclosure. [Figure 5A] 1 illustrates a front cross-sectional view of an exemplary surgical instrument according to some embodiments of the present disclosure. [Figure 5B] 1 illustrates a front cross-sectional view of an exemplary surgical instrument according to some embodiments of the present disclosure. [Figure 5C] 1 illustrates a front cross-sectional view of an exemplary surgical instrument according to some embodiments of the present disclosure. [Figure 5D] 1 illustrates a front cross-sectional view of an exemplary surgical instrument according to some embodiments of the present disclosure. [Figure 6A] 1 illustrates a top view of a portion of an exemplary surgical instrument according to some embodiments of the present disclosure. [Figure 6B] 1 illustrates a top view of a portion of an exemplary surgical instrument according to some embodiments of the present disclosure. [Figure 7A] 1 illustrates a portion of an exemplary surgical instrument positioned within a patient's eye during a surgical procedure, according to certain embodiments of the present disclosure. [Figure 7B] 7B shows an enlarged cross-sectional view of a portion of the exemplary surgical instrument of FIG. 7A positioned within a patient's eye during a surgical procedure, according to certain embodiments of the present disclosure. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

[0012] To facilitate understanding, wherever possible, identical reference numerals will be used to designate identical elements that are common to the figures. It is contemplated that elements and features of one embodiment may be beneficially incorporated in other embodiments without further reference.

[0013] The present disclosure relates generally to microsurgical instruments for ophthalmic surgical procedures and, more particularly, to microsurgical instruments having combined laser ablation, illumination and viscoelastic injection capabilities.

[0014] In some embodiments, the surgical instrument includes a base and a probe having a main lumen and a port at its distal tip. In certain embodiments, the probe may further include a single optical fiber in the main lumen, the single optical fiber configured to project both the laser light and the illumination light. According to certain embodiments, the laser light may be emitted from a distal end of the optical fiber and pass through a window at the distal tip of the probe, the laser light for disrupting ocular tissue, for example, the trabecular meshwork. At the same time, the illumination light may be emitted axially or laterally from the optical fiber to provide better visibility into the intraocular space during disruption of the trabecular meshwork. In certain other embodiments, separate optical fibers may be used to project the laser light and the illumination light. For example, in such embodiments, a first optical fiber may be used to project the laser light while one or more additional optical fibers may be used to project the illumination light. In further embodiments, once the trabecular meshwork is disrupted with the laser light, a viscoelastic material may be injected from a port of the probe into the disrupted trabecular meshwork to maintain the integrity of the intraocular space.

[0015] 1A-1B show schematic cross-sectional views of an eye 100 to illustrate the anatomy of the eye. As shown, the outer layer of the eye 100 includes the sclera 102, which serves as a support structure for the eye 100. The sclera meets the eyelids (not shown) and folds back to connect to the conjunctiva 134, a thin membrane that covers and protects the sclera 102. The front of the sclera 102 includes the cornea 104, which is a transparent tissue that allows light to enter the eye 100. The anterior chamber 106 is between the cornea 104 and the lens 108. The anterior chamber 106 contains a transparent fluid called aqueous humor 110, which helps to maintain the shape of the eye 100 and provides nutrition to the cornea 104, for example. The lens 108 is positioned within the eye 100 via zonular fibers 112 that are connected to the ciliary body 114. Within the anterior chamber 106, the iris 116 surrounds the lens 108 and forms a central pupil 118. The diameter of the pupil 118 controls the amount of light that passes from the lens 108 to the retina 120, which is located behind the vitreous cavity 122. The retina 120 receives the light collected by the lens 108 and converts it into neural signals that are sent via the optic nerve 124 to the brain for vision. The posterior chamber 126 is located between the iris 116 and the lens 108.

[0016] As shown in FIG. 1B, the anatomy of the eye 100 further includes the trabecular meshwork 128, which is a narrow band of tissue within the eye 100 that surrounds the iris 116 near the iridocorneal angle 132 where the iris 116 and cornea 104 meet. The trabecular meshwork 128 is a spongy tissue with micrometer-level pores formed by various fibrous layers that allows aqueous humor 110 to drain from the posterior chamber 106 into a circular pathway called Schlemm's canal 130 and ultimately into the blood system. Because aqueous humor 110 is constantly being produced by the eye 100, any obstruction within the trabecular meshwork 128 that blocks the outflow of aqueous humor 110 from the posterior chamber 106 causes increased intraocular pressure within the eye 100. Increased intraocular pressure can lead to damage to the optic nerve and ultimately reduced vision or blindness.

[0017] 2A-2B show a lateral cross-sectional view of the internal structure of an eye 100 during glaucoma surgery, e.g., a glaucoma procedure to remove obstructing trabecular meshwork or Schlemm's canal, using a prior art surgical instrument 200 with a probe 210 and a conventional injection device 250. In the example of Figs. 2A-2B, the probe 210 is a mechanical cutter, e.g., a goniotome with a mechanical blade, while the injection device 250 can be a syringe and needle or an injector, e.g., connected to a pneumatic system. Furthermore, the illumination light 142 is provided by a light source 140 external to the eye 100, e.g., an ophthalmic surgical microscope. However, optionally, an illumination probe, such as a vitreous surgical illuminator, can be inserted into the eye 100 simultaneously with the probe 210.

[0018] As shown in FIG. 2A , the probe 210 is inserted into the posterior chamber 106 through a small self-sealing incision 212 made in the cornea 104, for example, with a surgical scalpel. The distal end 202 of the probe 210 is advanced into the posterior chamber 106 until it contacts or is substantially adjacent to the trabecular meshwork 128 at the iridocorneal angle 132. The trabecular meshwork 128 is then disrupted by the probe 210 to form a fistula 220 that may open through the trabecular meshwork 128 to Schlemm's canal 130. The formation of the fistula 220 may improve the outflow of aqueous humor 110 from the posterior chamber 106 to Schlemm's canal 130, thereby relieving intraocular pressure in the eye 100 due to, for example, a compromised trabecular meshwork in the case of glaucoma or pre-glaucoma. In certain instances, multiple fistulas 220 are formed through the trabecular meshwork 128 along the circumference of the iridocorneal angle 132 to further improve the outflow of aqueous humor 110. In certain instances, the aqueous humor 110 may therefore flow beneath the conjunctiva 134 into an artificially created reservoir called a bleb (not shown).

[0019] In FIG. 2B, an injection device 250 is inserted into the eye 100 through the same incision 212 as the probe 210 (thus eliminating the need to remove the probe 210) or through a different incision 212. The distal tip 252 of the injection device 250 is advanced until it is substantially adjacent to or within the fistula 220 formed in the posterior chamber 106. A viscoelastic fluid 260 is then injected from the injection device 250 into the fistula 220 in the trabecular meshwork 128, which distends and / or holds open the fistula 220 and holds the posterior chamber 106 open to facilitate the flow of aqueous humor 110 from the posterior chamber 106 into Schlemm's canal 130. Thus, in the example of FIGS. 2A-2B, two or more microsurgical instruments are inserted and utilized simultaneously or sequentially during a glaucoma surgical procedure, unnecessarily increasing the complexity of the procedure.

[0020] 3 illustrates a perspective view of an improved surgical instrument 300 according to certain embodiments described herein. As shown in FIG. 3, the surgical instrument 300 includes a probe 310 and a base unit 320. The probe 310 is disposed partially longitudinally through a distal end 321 of the base unit 320 and may be directly or indirectly mounted within an internal chamber of the base unit 320. It should be noted that as described herein, a distal end or portion of a component refers to an end or portion that is closer to a patient's body during use of that component. On the other hand, a proximal end or portion of a component refers to an end or portion that is further away from the patient's body.

[0021] In certain embodiments, the base unit 320 is a handpiece having an exterior surface configured to be held by a user, such as a surgeon. For example, the base unit 320 can be ergonomically contoured to substantially fit a user's hand. In certain embodiments, the exterior surface can be textured or have one or more gripping features formed therein, such as one or more grooves and / or ridges. The base unit 320 can be made from any material commonly used for such instruments and suitable for ophthalmic surgery. For example, the base unit 320 can be formed from lightweight aluminum, polymer, or other suitable material. In some embodiments, the base unit 320 can be sterilized and used for more than one surgical procedure or can be a disposable device.

[0022] The base unit 320 further provides a number of ports 323 at its proximal end 325 (only one port 323 is shown in FIG. 3 ) for routing supply lines to the interior chamber of the base unit 320. For example, the port 323 may provide a connection between the base unit 320 and a supply line of a viscoelastic source (not shown) for viscoelastic injection. The port 323 may also provide a connection to a fiber optic cable that couples to a light source for providing laser light and illumination light.

[0023] 4A shows a plan view of the probe 310 and the distal end 321 of the base unit 320. As shown, the probe 310 may be an elongated laser cauterization member that may be inserted into the eye, for example, through an insertion cannula and / or an incision to perform a glaucoma surgical procedure, such as a goniotomy, trabeculotomy, or trabeculectomy. Thus, the probe 310 may be formed of a material suitable for minimally invasive glaucoma surgery (MIGS). In certain embodiments, the probe 310 includes one or more portions formed of a material configured to transmit laser light, visible light, ultraviolet light, infrared light, or any other type of light. For example, the probe 310 may include one or more portions formed of a translucent or transparent material, such as a plastic and / or polymeric material. The probe 310 may further include one or more portions formed of a more conventional surgical grade material, such as stainless steel and / or aluminum.

[0024] In certain embodiments, the probe 310 has a length L of about 15 mm to about 30 mm, although some embodiments may have a longer or shorter length. In certain embodiments, the probe 310 may include a hollow cylindrical (e.g., non-split) tube having an outer diameter of less than about 20 gauge. In some embodiments, the probe 310 is divided into two or more portions (e.g., regions or segments) having different sized outer diameters. For example, as shown in FIG. 4A, the probe 310 may include a proximal portion 412 having a larger outer diameter than a distal portion 414 that terminates at a distal tip 416. In certain embodiments, the proximal portion 412 has an outer diameter of about 23 gauge and the distal portion 414 has an outer diameter of about 25 gauge. In some embodiments, the proximal portion 412 has an outer diameter of about 25 gauge and the distal portion 414 has an outer diameter of about 27 gauge. In some embodiments, the proximal portion 412 has an outer diameter of about 27 gauge and the distal portion 414 has an outer diameter of about 29 gauge. In a further embodiment, an intermediate portion (not shown) is disposed between proximal portion 412 and distal portion 414 and has an outer diameter smaller than proximal portion 412 and larger than distal portion 414 .

[0025] In certain embodiments, the surgical instrument 300 further includes a stiffener 418 fixedly or slidably coupled to and substantially surrounding at least a portion of the probe 310. For example, the stiffener 418 is slidably coupled to an exterior surface 436 of the proximal portion 412 of the probe 310 and can extend from and retract into the base unit 320. The stiffener 418 can be adjustable relative to the probe 310, allowing a user to position the stiffener 418 at different points exterior to the base unit 320 along the length of the probe 310. Thus, by repositioning the stiffener 418 relative to the distal tip 416, a user can selectively adjust the level of stiffness of the probe 310, thereby manipulating the support force applied to the probe 310 during use of the surgical instrument 300 to stabilize the instrument.

[0026] As mentioned above, in certain embodiments, the surgical instrument 300 provides a single optical fiber configured to project both the laser light and the illumination light. Various examples of using a single optical fiber to project both the laser light and the illumination light are shown in Figures 4B-4C and 5A. In other certain embodiments, one or more optical fibers can be used to project the laser light, while one or more additional optical fibers can be used to project the illumination light. Various examples of using multiple fibers to project the laser light and the illumination light are shown in Figures 5B-5D.

[0027] 4B-4C show stylized longitudinal cross-sectional views of the distal portion 414 of the probe 310 with the optical fiber 440 housed therein. As shown, the probe 310 includes a main lumen 460 and one or more ports 422 near the distal tip 416, which has a protective window 430 located therein. In certain embodiments, the main lumen 460 has an at least substantially circular cross-section, as shown in FIGS. 5A-5D. However, other shapes of cross-section of the main lumen 460 are also contemplated, such as polygonal or elliptical. In the example shown in FIG. 4B, two substantially circular ports 422 are depicted on opposite sides of the main lumen 460 in the distal portion 414. The ports 422 are sized and shaped to allow for the injection of a viscoelastic material from the main lumen 406 to the exterior of the probe 310 during glaucoma surgery. However, any number, location and shape of ports 422 are contemplated. Additionally, although the probe 310 is described with respect to a viscoelastic fluid, it may also be utilized for the injection of other fluids, including irrigation fluids, during ophthalmic surgical procedures. A viscoelastic or other suitable fluid may be supplied to the lumen 406 by a fluid source 468 coupled to the probe 310, for example at port 323, via a supply line (not shown). While using the probe 310, a user may initiate the flow of viscoelastic material from the fluid source 468 to the lumen 406 and out of port 422 to the surgical site by actuation of one or more toggles (e.g., buttons, switches, etc.) on the base unit 320, a surgical console (not shown) in communication with the probe 310, or a foot pedal (not shown) in communication with the surgical console and / or the probe 310.

[0028] The optical fiber 440 may be designed to operate as an optical waveguide and propagate laser light 441 through its terminal end 442. The properties of the laser light 441 propagating through the optical fiber 440 are such that the laser light 441 causes disruption of the trabecular meshwork and / or Schlemm's canal fibers within the path of the laser light 441. Disruption refers to the destruction of tissue by rapid ionization of its molecules. In some examples, the laser light 441 may be generated by a laser source 464 optically coupled to the optical fiber 440 using a fiber optic cable, as described above. In some embodiments, the laser light 441 propagated by the optical fiber 440 is ultraviolet ("UV") (<350 nm) laser light. In other embodiments, the laser light 441 is an argon blue-green laser light (488 nm), a Nd-YAG laser light (532 nm) such as a frequency doubled Nd-YAG laser light, a krypton red laser light (647 nm), a diode laser light (805-810 nm) or other suitable type of laser light for ophthalmic surgery.

[0029] In some embodiments, the laser source 464 can generate laser light 441 having a pulse rate in the range of about 1 kilohertz (kHz) to about 500 kHz. This range can effectively provide for the destruction of the trabecular meshwork and / or Schlemm's canal. Other pulse rate ranges can also provide for the destruction and are contemplated as well. In some examples, the laser source 464 generates picosecond or femtosecond laser light 441. In some embodiments, the laser source 464 can generate continuous coherent laser light 441. For example, the laser source 464 can generate continuous coherent laser light 441 at low power. While using the probe 310, the user can initiate the transmission of laser light 441 from the laser source 464 through the probe 310 to the surgical site by actuation of one or more toggles (e.g., buttons, switches, etc.) on the base unit 320, a surgical console (not shown) in communication with the probe 310, or a foot pedal (not shown) in communication with the surgical console and / or the probe 310, as in the case of performing an injection of a viscoelastic material.

[0030] In certain embodiments, the optical fiber 440 is disposed within the main lumen 460 and terminates at a terminating end 442 disposed at or adjacent to the window 430 such that the laser light 441 projected from the optical fiber 440 is projected distally through the window 430 with sufficient power to cut the trabecular meshwork and / or Schlemm's canal fibers located distal to the window 430. Thus, the window 430 comprises an optically clear or transparent material. Examples of transparent materials include sapphire, fused silica, or other glass or ceramic materials with high transition temperatures. In certain aspects, the transparent material has refractive power, and in certain other aspects, the transparent material does not have refractive power. Refractive power (also referred to as refractive power, refractive power, focusing power, or converging power) is the degree to which a lens, mirror, or other optical system converges or diverges light. Thus, the window 430 itself can be a lens, such as a spherical lens or an aspheric lens with a concave or convex surface.

[0031] In the embodiment shown in FIG. 4B, the optical fiber 440 is rigidly suspended within the main lumen 460 such that the optical fiber 440 is separated from the interior sidewall 426 of the probe 310 and the optical fiber 440 is circumferentially surrounded by a space 428. The space 428 formed between the optical fiber 440 and the interior sidewall 426 of the probe 310 provides a coaxial path for distal flow of the viscoelastic material through the probe 310. In some embodiments, the optical fiber 440 may be centrally disposed within the main lumen 460 such that the radial distance between the interior sidewall 426 and the optical fiber 440 is uniform along the circumference of the optical fiber 440. However, in certain embodiments, the optical fiber 440 may be disposed (e.g., coupled to the bottom) along the interior sidewall 426 (not shown). For example, the optical fiber 440 may be coupled to the interior sidewall 426 along its longitudinal length and extend between the ports 422. The optical fiber 440 may be coupled to the inner sidewall 426 using any suitable adhesive or bonding mechanism, such as an epoxy or acrylic adhesive.

[0032] In the embodiment of Figures 4B-4C, the optical fiber 440 is further configured to propagate illumination light 443 in addition to and separate from the laser light 441. For example, an illumination source 466 can be used to provide the illumination light 443 to the optical fiber 440 in a continuous or pulsed manner. The optical fiber 440 propagates the illumination light 443 in one of a variety of ways to illuminate the intraocular space, e.g., the anterior chamber. Examples of illumination sources 466 include a UV (ultraviolet) light source, a violet light source, a blue light source, a white light source, an infrared ("IR") or near-IR light source, or any other suitable type of illumination source. For example, an LED-based illumination source 466 can be utilized. In a further example, a xenon or halogen-based illumination source 466 can be utilized. While using the probe 310, a user may initiate the transmission of illumination light 443 from the illumination source 466 through the probe 310 to the surgical site by actuation of one or more toggles (e.g., buttons, switches, etc.) on the base unit 320, a surgical console (not shown) in communication with the probe 310, or a foot pedal (not shown) in communication with the surgical console and / or probe 310, as well as the injection of viscoelastic material and / or propagation of laser light 441.

[0033] In embodiments where a single optical fiber 440 is used to project both the laser light and the illumination light, the laser light source 464 may be configured to focus the laser light 441 into the core of the optical fiber 440, such that the laser light 441 is transmitted through the core. In certain embodiments, the illumination light source 466 may be configured to focus the illumination light 443 into both the core and the cladding of the optical fiber 440, in which case both the cladding and the core transmit the illumination light 443. In yet some other embodiments, the illumination light source 466 may be configured to focus the illumination light 443 only into the core or the cladding, in which case only one of the core or the cladding transmits the illumination light 443. Thus, an optical fiber 440 including a core and a cladding may transmit the laser light 441 (through the core) and the illumination light 43 (through the cladding and the core) within the same fiber. In certain embodiments, the single optical fiber 440 may include two or more cores. For example, the single optical fiber 440 may be a multi-core fiber (MCF). In such embodiments, the laser light 441 and / or the illumination light 443 may propagate through two or more cores of a single optical fiber 440. In certain embodiments, within the optical fiber 440, the laser light 441 may propagate through one core and the illumination light 443 may propagate through a different core; thus, the optical fiber 440 may include one or more cores through which the laser light 441 and the illumination light 443 propagate separately.

[0034] In certain embodiments, the illumination light 443 is projected axially from the terminal end 442 of the optical fiber 440 together with the laser light 441 (as shown in FIG. 4B). In certain embodiments, the illumination light 443 is projected diffusively from the terminal end 442. In certain embodiments, the illumination light 443 is internally reflected within the optical fiber 440 and thus is projected only from the terminal end 442. For example, the optical fiber 440 is an edge-emitting optical fiber. In certain embodiments, the illumination light 443 is not fully reflected within the optical fiber 440 and may be emitted through a sidewall of the cladding instead of or in addition to the terminal end 442. For example, the optical fiber 440 is an edge-emitting or side-emitting optical fiber and the illumination light 443 is emitted radially outward therefrom (as shown in FIG. 4). The illumination light 443 is co-propagated with the laser light 441 or is sequentially pulsed with the laser light 441. In certain embodiments, the propagation of the illumination light 443 through the optical fiber 440 and into the intraocular space can be modulated by using different types of illumination light sources 466, using different materials for the optical fiber 440, changing the physical arrangement of the optical fiber 440 within the probe 310, and / or using different materials for the probe 310.

[0035] 4C illustrates an example of an optical fiber 440 that propagates both laser light 441 and illumination light 443. In the example of FIG. 4C, the laser light 441 and illumination light 443 are emitted through a terminal end 442 of the optical fiber 440, and the illumination light 443 is also emitted radially outward from the optical fiber 440. In the example of FIG. 4C, the laser light 441 may be focused into the core of the optical fiber 440, while the illumination light 443 is focused into the core and / or cladding of the optical fiber 440. However, as previously mentioned, in certain other embodiments, the illumination light 443 may instead be focused only into the cladding of the optical fiber 440. In such an embodiment (not shown), the illumination light 443 may be emitted only axially through the terminal end 442 of the optical fiber 440.

[0036] In certain embodiments, the optical fiber 440 is communicatively coupled to a digital visualization system, such as the NGENUITY® 3D visualization system from Alcon. Other digital visualization systems, including those manufactured by other manufacturers, are also contemplated for use with the embodiments described herein. Utilization of a digital visualization system may allow modification of the color and intensity of the illumination light 443 emitted from the optical fiber 440 by adjusting hue, saturation, gamma, tint, and / or other light parameters.

[0037] In certain embodiments, the optical fiber 440 has a diameter of about 20 μm to about 120 μm, such as a diameter of about 40 μm to about 100 μm. For example, the optical fiber 440 has a diameter of about 50 μm to about 80 μm. However, smaller or larger diameters are also contemplated. In some embodiments, an optical sleeve assembly including multiple optical fibers 440 is utilized. For example, an optical sleeve including multiple optical fibers 440 having uniform or different diameters can be utilized. In further embodiments, the optical fiber 440 is a multimode end-emitter optical fiber, a single mode end-emitter optical fiber, or the like.

[0038] 5A-5D show exemplary cross-sectional front views of the probe 310 of FIGS. 4A-4C, in which an optical fiber 440 is housed for projecting both laser light and illumination light. As shown, the probe 310 has a circular cross-section defined by an inner sidewall 426 and an outer surface 436. In general, the optical fiber 440, according to an embodiment of the present disclosure, includes a core 544 and a cladding 546 circumferentially surrounding the core 544. The core 544 may include any transparent material, such as fused silica or glass. In some embodiments, the core 544 is doped. For example, the core 544 may be silica doped with germanium. Doping the core 544 with germanium or a similar dopant increases the refractive index of the core 544 compared to the refractive index of the material of the cladding 546, thus enabling laser and light guiding properties within the core 544.

[0039] The cladding 546 may also comprise a transparent material such as fused silica or glass. In some embodiments, the cladding 546 is doped in addition to or instead of doping the core 544. For example, the cladding 546, which may comprise fused silica, is doped with a dopant that reduces the refractive index of the cladding 546 relative to the refractive index of the core 544. Examples of dopants include fluorine (F), chlorine (Cl), boron (B), and the like. When doped, the cladding 546 has a lower refractive index than the core 544, thus enabling light guiding properties within the core 544. Although one cladding 546 is shown in each of FIGS. 5A-5D, the optical fiber 440 may further include one or more additional claddings.

[0040] In one example, the core 544 has a diameter in the range of 5 μm to about 100 μm, such as a diameter of about 20 μm to about 80 μm, such as a diameter of about 75 μm. However, smaller or larger diameters are also contemplated. In one example, the cladding 546 has a thickness of about 5 μm to about 50 μm, such as a thickness of about 15 μm to about 40 μm, such as a thickness of about 25 μm. However, smaller or larger thicknesses are also contemplated.

[0041] In a particular embodiment shown in FIG. 5A, the optical fiber 440 is disposed within a sleeve 548. The sleeve 548 can be directly or indirectly coupled to the exterior of the cladding 546 and circumferentially surround the cladding 546 and the core 544 of the optical fiber 440 therein. The sleeve 548 can function as a tubular structure to provide structural support, rigidity, and suspension for the optical fiber 440 within the main lumen 460 of the probe 310. In a particular example, the sleeve 548 facilitates central axial alignment of the optical fiber 440 within the main lumen 460 such that the radial distance D between the exterior surface of the sleeve 548 and an interior sidewall of the probe 310, e.g., the interior sidewall 426, is substantially uniform along the circumference of the sleeve 548. Like the core 544 and the cladding 546, the sleeve 548 can include a transparent material such as fused silica and glass. In further embodiments, the sleeve 548 is doped with a dopant to manipulate the refractive index of the sleeve 548 as needed. Sleeve 548 may have a thickness of about 5 μm to about 50 μm, such as about 15 μm to about 40 μm, such as about 25 μm thick. However, smaller or larger thicknesses are contemplated. In embodiments in which sleeve 548 is directly coupled to optical fiber 440, the inner surface of sleeve 548 may have an inner diameter substantially similar to the outer diameter of optical fiber 440.

[0042] Although the optical fiber 440 is shown as being centrally disposed within the main lumen 460, in certain embodiments it may be disposed against the interior sidewall 426 of the probe 310, with or without the sleeve 548. For example, the optical fiber 440 may be bonded to the interior sidewall 426 along a portion of its length between the ports 422, as shown by example location P in FIG. 5A. Such a configuration may improve the flow of, for example, viscoelastic materials through the interior of the probe 310. The optical fiber 440 may be bonded or joined to the interior sidewall 426 by any suitable adhesive or bonding mechanism. For example, the exterior surface of the cladding 546 or sleeve 548 may be bonded to the interior sidewall 426 of the probe 310 using an epoxy or acrylic adhesive. However, other suitable adhesives are contemplated.

[0043] 5A-5C show an exemplary front cross-sectional view of the probe 310 having at least two optical fibers 540a, 540b housed therein. Thus, the first optical fiber 540a can be utilized to propagate laser light for tissue cutting, and the second optical fiber 540b can be utilized to propagate illumination light for illumination of the intraocular space. Each of the optical fibers 540a, 540b further includes a core 544a, 544b and a cladding 546a, 546b, respectively. The cores 544a, 544b and the claddings 546a, 546b can be formed of any material suitable for propagating the laser and illumination light beams, respectively. For example, the cores 544a, 544b and the claddings 546a, 546b can include a transparent material, such as fused silica or glass, as previously described. The cores 544a, 544b and claddings 546a, 546b may be further doped with one or more dopants depending on the desired refractive properties of the optical fibers 540a, 540b, respectively.

[0044] The dimensions of the optical fibers 540a, 540b, including the cores 544a, 544b and claddings 546a, 546b, can be substantially similar to the dimensions of the optical fiber 440, core 444, and cladding 446 described above. Although shown in Figures 5A-5C as having different dimensions, the optical fibers 540a, 540b, cores 544a, 544b, and claddings 546a, 546b can have similar or different dimensions to one another.

[0045] As shown in FIG. 5B, both optical fibers 540a, 540b are disposed within a secondary lumen 562 of sleeve 558, which itself may be centrally disposed within main lumen 460 or disposed in contact with interior sidewall 426, for example, between ports 422. Similar to sleeve 548, sleeve 558 may provide structural support and containment for optical fibers 540a, 540b within main lumen 460 of probe 310. Sleeve 558 may include transparent materials such as fused silica and glass. In further embodiments, sleeve 558 is doped with a dopant to engineer the refractive index of sleeve 558 as needed. Sleeve 558 may have any suitable thickness to provide suitable support and rigidity for optical fibers 540a, 540b, such as from about 5 μm to about 50 μm thick, such as from about 15 μm to about 40 μm thick. For example, sleeve 558 may have a thickness of about 25 μm. However, smaller or larger thicknesses are also contemplated. In certain embodiments, a transparent filler material may be used within the secondary lumen 562 to prevent migration of the optical fibers 540a, 540b therein. For example, an adhesive may fill all areas within the secondary lumen 562 that are not occupied by the optical fibers 540a, 540b. In other embodiments, the optical fibers 540a, 540b are disposed within the secondary lumen 562 without utilizing a filler material.

[0046] 5C illustrates an alternative exemplary arrangement of the optical fibers 540a, 540b without utilizing a sleeve 558. As shown, the optical fibers 540a, 540b are disposed through a spacer tube 570 having one or more longitudinal bores 572 drilled therethrough to allow for the placement of the optical fibers 540a, 540b. The spacer tube 570 may act in a substantially similar manner as the sleeve 558 to provide structural support and containment for the optical fibers 540a, 540b. In certain embodiments, the spacer tube 570 is centrally disposed or suspended within the main lumen 460. However, in certain embodiments, the spacer tube 570 is disposed in contact with the interior sidewall 426 between the ports 422. The spacer tube 570 may be formed from any suitable transparent material, including fused silica and / or glass.

[0047] 5D shows an exemplary front cross-sectional view of the probe 310 having a first optical fiber 550a configured to carry laser light and a plurality of second optical fibers 550b surrounding the first optical fiber 550a and configured to carry illumination light. The first optical fiber 550a and the second optical fiber 550b each include a core 554a, 554b and a cladding 556a, 556b. The materials and dimensions of the cores 554a, 554b and the claddings 556a, 556b may be substantially the same as the materials and dimensions of the optical fibers 440 and 540 described above. However, as shown in FIG. 5D, the dimensions of the second optical fiber 550b may be smaller than the dimensions of the first optical fiber 550a to provide a space 428 in the main lumen 460 with sufficient volume for a viscoelastic or other fluid to flow therethrough.

[0048] As shown in FIG. 5D, the first optical fiber 550a is circumferentially surrounded by the second optical fiber 550b along its outer diameter. In other words, the ring of second optical fibers 550b is disposed around and in contact with the cladding 556a of the first optical fiber 550a such that the centers of the cores 554a are equidistant or at least substantially equidistant from the centers of the cores 554b. In a further embodiment, an optional sleeve 568 is disposed around the plurality of second optical fibers 550b and configured to hold the second optical fibers 550b rigidly against the first optical fibers 550a. The sleeve 568 may have any suitable thickness and dimensions to ensure that the second fibers 550b are tightly packed and there is no room for the second fibers 550b to loosen or move. Although shown as being centrally suspended within the main lumen 460, the first optical fiber 550a and the surrounding second optical fiber 540b may be disposed in any suitable location within the main lumen 460. For example, the first optical fiber 550a and the surrounding second optical fiber 550b may be coupled to the interior sidewall 426 of the probe 310 along a length portion between the ports 422.

[0049] In addition to utilizing different arrangements of optical fibers within the probe of the surgical instrument, the propagation of illumination light to the surgical area (e.g., intraocular space) may be altered by utilizing different materials in the probe and / or using masks. For example, the probe may include one or more portions formed of a translucent or transparent material and one or more portions formed of an opaque or semi-opaque material. In some embodiments, the distal portion of the probe is formed of a translucent or transparent material, while the proximal portion of the probe is formed of a metal, such as stainless steel or aluminum. In some embodiments, only the distal tip of the probe (including the area around the port) is formed of a translucent or transparent material, and the remainder of the distal portion and the entire proximal portion are formed of a metal. In further embodiments, both the distal and proximal portions of the probe are formed entirely of a translucent or transparent material.

[0050] 6A-6B show exterior side views of the probe 610 with different exemplary arrangements of opaque material 680 and semi-transparent or transparent material 682 to modify the propagation of illumination light through the distal portion 614 and the proximal portion 612 of the probe 610. The opaque material 680 may refer to any suitable material, layer, device, or mechanism for reducing or preventing the transmission of illumination light therethrough. For example, the opaque material 680 may refer to an area of ​​the probe 610 that has a higher refractive index relative to other areas of the probe 610. In certain examples, the opaque material 680 may refer to an opaque or semi-opaque portion of the probe 610 through which reduced or no illumination light may pass. In other examples, the opaque material 680 may refer to an opaque or semi-opaque film or layer applied to an exterior or interior surface of the probe 610. In yet other examples, the opaque material 680 may refer to a metal portion of the probe 610, such as a stainless steel or other suitable alloy portion. In any form, the opaque material 680 can be arranged in any suitable configuration along the length L of the probe 610 to provide optimal illumination of the intraocular space and reduce glare to a user of the surgical instrument caused by the illuminating light.

[0051] In one exemplary embodiment shown in FIG. 6A, the opaque material 680 substantially forms or surrounds the proximal portion 612 and the distal portion 614 of the probe 610, except for a translucent or transparent portion 682 adjacent the port 622. The translucent or transparent portion 682 begins proximal to the port 622 and terminates at the distal tip 616. As a result, transmission of illumination light from one or more optical fibers in the probe 610 to the surrounding environment is substantially reduced or prevented along most of the length L covered by the opaque material 680 proximal to the translucent or transparent portion 682. Rather, most of the illumination light emitted by the probe 610 in FIG. 6A may propagate radially outward from the translucent or transparent portion 682 over 360° near the distal tip 616. Thus, illumination of the probe 610 during use can be limited to areas near the surgical site (e.g., the trabecular meshwork) where tissue fibers are laser ablated during glaucoma surgery and adjacent the port 622 through which viscoelastic or other fluids can be injected, thus providing improved visibility with reduced glare to the user.

[0052] 6B illustrates another exemplary arrangement of opaque material 680 and translucent or transparent material 682 of a probe 610. In FIG. 6B, the distal portion 614 of the probe 610 is substantially formed of the translucent or transparent material 682, except for the region of opaque material 680 at the distal tip 616. For example, during glaucoma surgery, the distal tip 616 of the probe 610 is often placed in close proximity to or in contact with the trabecular meshwork or surrounding tissue, where excess illumination emitted radially outward near the distal tip 616 can cause undesirable damage to adjacent tissue. Thus, utilizing the material arrangement of FIG. 6B prevents radially outward transmission of illumination light near the distal tip 616, thereby reducing or eliminating undesirable damage to tissue adjacent the surgical site.

[0053] 7A-7B show side cross-sectional views of the internal structure of an eye 100 during the performance of a glaucoma procedure, such as a glaucoma procedure to remove damaged trabecular meshwork, with a surgical instrument 700 having a base unit 720 and a probe 710. The probe 710 is representative of the probes 310 and 610 previously described, either of which may be utilized as described herein. As shown in FIG. 7A, the probe 710 is inserted into the anterior chamber 106 of the eye 100 through a small self-sealing incision 212 made in the cornea 104, such as with a surgical blade. The distal tip 716 of the probe 710 is advanced within the anterior chamber 106 until it contacts or is substantially adjacent the trabecular meshwork 128 at the iridocorneal angle 132. A user, e.g., a surgeon, can thus activate a laser light source 764 coupled to an optical fiber (not shown) disposed within the surgical instrument 700 such that laser light 741 propagates within the optical fiber and is emitted axially therefrom through a window (not shown) in the distal tip 716 of the probe 710. In certain embodiments, the laser light source 764 is activated by the surgeon depressing a foot pedal (not shown) in wired or wireless communication with a surgical console that drives the laser light source 764. For example, the laser light source 764 may be activated by the surgeon depressing the foot pedal to a first position.

[0054] In FIG. 7A , the laser light 741 delivered by the surgical instrument 700, for example, disrupts the trabecular meshwork 128 to form a fistula 220 therein. As previously described, the fistula 220 can improve the outflow of aqueous humor 110 from the anterior chamber 106 to reduce or relieve intraocular pressure within the eye 100 that may result from a compromised trabecular meshwork 128. In certain examples, the surgical instrument 700 forms multiple fistulas 220 in the trabecular meshwork 128 around the circumference of the iridocorneal angle 132 to further increase the outflow of aqueous humor 110. The aqueous humor 110 flows into Schlemm's canal 130, which facilitates the aqueous humor 110 being gradually absorbed into the patient's circulatory system. In certain embodiments, the aqueous humor 110 can further flow from Schlemm's canal 130 to an artificially created reservoir called a bleb (not shown) beneath the conjunctiva 134.

[0055] Simultaneously or sequentially with the propagation of the laser light 741, the surgeon may activate an illumination light source 766 coupled to the same or different optical fiber as the laser light source 764 such that the illumination light 743 propagates in the corresponding optical fiber and is emitted axially or laterally from the probe 710. In certain examples, the illumination light source 766 is activated before inserting the probe 710 into the anterior chamber 106 or as the distal tip 716 is advanced within the anterior chamber 106 toward the trabecular meshwork 128. In certain examples, the illumination light source 766 is activated when the distal tip 716 contacts or is substantially adjacent to the trabecular meshwork 128. The propagation of the illumination light 743 during the procedure may improve visualization of the surgical site, e.g., the trabecular meshwork 128 and fistula 220, during the surgical procedure, as compared to external illumination provided, for example, by an ophthalmic surgical microscope. In certain embodiments, the illumination light source 766 may be activated by the surgeon pressing the same foot pedal that controls the laser light source 764. For example, the illumination source 766 may be activated by the surgeon depressing a foot pedal to a second position different from the first position for activating the laser source 764 .

[0056] In the enlarged view of Figure 7B, after the fistula 220 is formed, the laser source 764 is deactivated and the distal tip 716 of the probe 710 is advanced into or proximate to the fistula 220. The surgeon can then activate a fluid source 768 coupled to the probe 710 such that the viscoelastic material 260 is injected laterally through a lumen (not shown) of the probe 710 and out a port 722 near the distal tip 761 into the fistula 220 (and thus into the trabecular meshwork 128 and / or Schlemm's canal 130). The viscoelastic material 260 may be injected in opposite directions from the probe 710, for example, by two ports 722 located on opposite sides of the probe 710. In certain instances, the surgeon can rotate the probe 310 to vary the radial injection direction of the viscoelastic material 260 from the port 722 and can advance or retract the probe 710 further through the fistula 220 to disperse the viscoelastic material 260 within the fistula 220 as needed. Injecting the viscoelastic material 260 into the trabecular meshwork 128 and / or Schlemm's canal 130 can facilitate expansion and maintenance of the fistula 220 following glaucoma surgery and can also maintain the integrity of the anterior chamber 106.

[0057] In certain embodiments, injection of the viscoelastic material 260 from the fluid source 768 is actuated by the surgeon depressing the same foot pedal that controls the laser source 764 and the illumination source 766. For example, the fluid source 768 may be actuated by depressing the foot pedal to a third position different from the first and second positions. In certain embodiments, the third position may include a range of foot pedal positions that correspond to different flow rates of the fluid source 768, and thus, may vary the amount of viscoelastic material 260 injected. After the viscoelastic material 260 has been injected into the fistula 220, the probe 710 may be removed from the eye 100.

[0058] In summary, embodiments of the present disclosure include devices and structures for performing glaucoma-related surgery. Specifically, the above-mentioned surgical instruments combine the functionality of laser cauterization, intraocular illumination, and viscoelastic injection, thus enabling more efficient performance of, for example, goniotomy, trabeculotomy, and trabeculectomy. Utilization of a laser probe allows for easy disruption of tissue fibers in the trabecular meshwork and surrounding tissue, while inclusion of a fluid port in the probe allows for fluid injection near the surgical site without removing the laser probe or requiring a separate injection device. Additionally, propagation of illumination light through the laser probe facilitates diffuse intraocular illumination for improved visibility during surgery. Thus, the described embodiments enable the performance of more efficient, less invasive, and safer glaucoma-related surgery.

[0059] Although glaucoma surgery is discussed as one example of a surgical procedure that may benefit from the described embodiments, other surgical procedures may similarly benefit from the advantages of the surgical devices and systems described herein.

[0060] While the forgoing is directed to embodiments of the present disclosure, other and further embodiments of the disclosure may be devised without departing from the basic scope thereof, which is determined by the following claims.

[0061] Exemplary embodiments Embodiment 1: A surgical instrument for an ophthalmic procedure includes a handle, a probe coupled to the handle, the probe including a tube, an optically clear or transparent window disposed within a distal end of the tube, one or more optical fibers extending at least partially through the tube, the one or more optical fibers configured to transmit laser light for illuminating an area near the window to ablate the patient's trabecular meshwork, the one or more optical fibers further transmitting illumination light for illuminating the patient's intraocular space, and a first port and a second port formed near the distal end of the tube for injecting a viscoelastic fluid into the ablated trabecular meshwork.

[0062] Embodiment 2: The surgical instrument of embodiment 1, wherein the illumination light is focused into the cladding of one of the one or more optical fibers.

[0063] Embodiment 3: The surgical instrument of embodiment 1, wherein the illumination light is focused into one core of the one or more optical fibers.

[0064] Embodiment 4: The surgical instrument of embodiment 3, wherein the illumination light is also focused into one core of the one or more optical fibers.

[0065] Embodiment 5: The surgical instrument of embodiment 1, wherein the laser light and the illumination light are simultaneously projected through one or more optical fibers.

[0066] Embodiment 6: The surgical instrument of embodiment 1, wherein the laser light and the illumination light are pulsed sequentially through one or more optical fibers.

[0067] Embodiment 7: The surgical instrument of embodiment 1, wherein the window comprises a lens.

[0068] Embodiment 8: The surgical instrument of embodiment 1, wherein the window comprises at least one of sapphire, fused silica, glass, or ceramic materials.

[0069] Embodiment 9: The surgical instrument of embodiment 1, further comprising a lens housed within the tube, the lens being disposed between the one or more optical fibers and the window.

[0070] Embodiment 10: The surgical instrument of embodiment 1, wherein the tube has a gauge of 25 or less.

Claims

1. 1. A surgical instrument for an ophthalmic procedure, comprising: handle, A probe coupled to the handle wherein the probe comprises Tube and an optically clear or transparent window disposed within the distal end of the tube; one or more optical fibers extending at least partially through the tube, the optical fibers being configured to transmit laser light for illuminating an area proximate the window to ablate the patient's trabecular meshwork, the optical fibers further transmitting illumination light for illuminating an intraocular space of the patient; a first port formed near the distal end of the tube for injecting a viscoelastic fluid into the ablated trabecular meshwork; 4. A surgical instrument, comprising:

2. The surgical instrument of claim 1 , wherein the one or more optical fibers include a single optical fiber configured to project the laser light and the illumination light.

3. The surgical instrument of claim 2 , wherein the laser light is focused into a core of the single optical fiber and the illumination light is focused into a cladding of the single optical fiber.

4. The surgical instrument of claim 3 , wherein the illumination light is also focused to the core of the single optical fiber.

5. The surgical instrument of claim 1 , wherein the one or more optical fibers include a first optical fiber configured to project the laser light and a second optical fiber configured to project the illumination light.

6. The surgical instrument of claim 1 , wherein the laser light is a pulsed laser light.

7. The surgical instrument of claim 6 , wherein the pulsed laser light is a picosecond laser light.

8. The surgical instrument of claim 6 , wherein the pulsed laser light is a femtosecond laser light.

9. The surgical instrument of claim 1 , wherein the laser light is a continuous laser light.

10. The surgical instrument of claim 1 , wherein the illumination light is a pulsed illumination light.

11. The surgical instrument of claim 1 , wherein the laser light and the illumination light are projected axially from the one or more optical fibers.

12. The surgical instrument of claim 1 , wherein the tube further comprises a translucent or transparent material to facilitate transmission through the tube of illumination light emitted radially outward from the one or more optical fibers.

13. 10. The surgical instrument of claim 1, wherein the one or more optical fibers are positioned within the tube such that an injection space circumferentially surrounds the one or more optical fibers, and the one or more optical fibers extend distally beyond the first port.

14. The surgical instrument of claim 13, wherein the injection space facilitates flow of the viscoelastic fluid from a fluid source into the tube and through the first port.

15. 2. The surgical instrument of claim 1, further comprising a second port formed near the distal end of the tube and opposite the first port, the second port for injecting the viscoelastic fluid into the ablated trabecular meshwork in a direction opposite the viscoelastic fluid injected from the first port.